GCR Interactive: Pharmaceuticals Health, Data and Privacy
Event summary
Health data is a top enforcement priority for antitrust and privacy enforcers around the globe. This session will explore the effectiveness of addressing privacy concerns via merger remedies and the possible lasting effects of this first leap in engaging antitrust tools to safeguard health data. The panel will consider the approaches taken by the US DOJ, European Commission and Australian Competition and Consumer Commission and ask what we can learn from their reviews of the merger.
Cooley partner Tanisha James is speaking on this panel.
Event details and registration
This event is complimentary for in-house counsel
For more information, please email Rebecca Lanz.
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.